| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |